1-9 of 9
Lin Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax

Toshihisa Satta, Lin Li, Sri Lakshmi Chalasani, Xiaoyan Hu, Jewel Nkwocha, Kanika Sharma, Maciej Kmieciak, Mohamed Rahmani, Liang Zhou, Steven Grant
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1332–1343.
https://doi.org/10.1158/1078-0432.CCR-22-2729
Published: 03 April 2023
View article titled, Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
Open the PDF for Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax in another window
Includes: Supplementary data
Journal Articles

Plasma Tumor Mutation Burden and Response to Pembrolizumab—Letter

Xiaoyan Li, Yu Xu, Guoqiang Wang, Lin Li
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (13): 3491.
https://doi.org/10.1158/1078-0432.CCR-20-0903
Published: 01 July 2020
View article titled, Plasma Tumor Mutation Burden and Response to Pembrolizumab—Letter
Open the PDF for Plasma Tumor Mutation Burden and Response to Pembrolizumab—Letter in another window
Journal Articles

Whole-body Imaging of Cell Death Provides a Systemic, Minimally Invasive, Dynamic, and Near-real Time Indicator for Chemotherapeutic Drug Toxicity

Steven E. Johnson, Andrey Ugolkov, Chad R. Haney, Gennadiy Bondarenko, Lin Li, Emily A. Waters, Raymond Bergan, Andy Tran, Thomas V. O'Halloran, Andrew Mazar, Ming Zhao
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1331–1342.
https://doi.org/10.1158/1078-0432.CCR-18-1846
Published: 15 February 2019
View article titled, Whole-body Imaging of Cell Death Provides a Systemic, Minimally Invasive, Dynamic, and Near-real Time Indicator for Chemotherapeutic Drug Toxicity
Open the PDF for Whole-body Imaging of Cell Death Provides a Systemic, Minimally Invasive, Dynamic, and Near-real Time Indicator for Chemotherapeutic Drug Toxicity in another window
Includes: Supplementary data
Journal Articles

Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma

Daoxiang Zhang, Lin Li, Hongmei Jiang, Brett L. Knolhoff, Albert C. Lockhart, Andrea Wang-Gillam, David G. DeNardo, Marianna B. Ruzinova, Kian-Huat Lim
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (7): 1748–1759.
https://doi.org/10.1158/1078-0432.CCR-16-1121
Published: 02 April 2017
View article titled, Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma
Open the PDF for Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract A16: Establishment and characterization of CCGL007, a novel human chronic lymphocytic leukemia cell line

Ching-Chuan Kuo, Chih-Cheng Chen, Chih-Hsiang Huang, Lin Li-Mei
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): A16.
https://doi.org/10.1158/1557-3265.PDX16-A16
Published: 15 August 2016
View article titled, Abstract A16: Establishment and characterization of CCGL007, a novel human chronic lymphocytic leukemia cell line
Journal Articles

Abstract B50: A new class of diazonamide analogs with improved antitumor activity

Lin Li, Qi Wei, Ming Zhou, Vijayashree Ramesh, Xiaodong Wang, Patrick G. Harran, Lai Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14_Supplement): B50.
https://doi.org/10.1158/1078-0432.TCMUSA10-B50
Published: 02 February 2016
View article titled, Abstract B50: A new class of diazonamide analogs with improved antitumor activity
Journal Articles

The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2

Feifei Qi, Ting He, Lin Jia, Nan Song, Lifang Guo, Xuhui Ma, Chunying Wang, Min Xu, Yan Fu, Lin Li, Yongzhang Luo
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (13): 3071–3080.
https://doi.org/10.1158/1078-0432.CCR-14-2785
Published: 30 June 2015
View article titled, The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2
Open the PDF for The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2 in another window
Includes: Supplementary data
Journal Articles

A Multiparametric Serum Kallikrein Panel for Diagnosis of Non–Small Cell Lung Carcinoma

Chris Planque, Lin Li, Yingye Zheng, Antoninus Soosaipillai, Karen Reckamp, David Chia, Eleftherios P. Diamandis, Lee Goodglick
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1355–1362.
https://doi.org/10.1158/1078-0432.CCR-07-4117
Published: 03 March 2008
View article titled, A Multiparametric Serum Kallikrein Panel for Diagnosis of Non–Small Cell Lung Carcinoma
Open the PDF for A Multiparametric Serum Kallikrein Panel for Diagnosis of Non–Small Cell Lung Carcinoma in another window
Includes: Supplementary data
Journal Articles

A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

Yingye Zheng, Dionyssios Katsaros, Shannon J.C. Shan, Irene Rigault de la Longrais, Mauro Porpiglia, Andreas Scorilas, Nam W. Kim, Robert L. Wolfert, Iris Simon, Lin Li, Ziding Feng, Eleftherios P. Diamandis
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (23): 6984–6992.
https://doi.org/10.1158/1078-0432.CCR-07-1409
Published: 03 December 2007
View article titled, A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy
Open the PDF for A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy in another window
Includes: Supplementary data